BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$340.99M
↑ 703% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-56.59M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $340.99M | +13508.9% |
| 2024 | $-2.54M | +97.5% |
| 2023 | $-103.71M | +30.1% |
| 2022 | $-148.44M | +16.5% |
| 2021 | $-177.72M | -1.7% |
| 2020 | $-174.76M | -75.7% |
| 2019 | $-99.45M | -5.6% |
| 2018 | $-94.22M | -64.1% |
| 2017 | $-57.41M | -18.1% |
| 2016 | $-48.61M | - |